Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.
All Topics

Multi-drug Resistant Tuberculosis

 
MSF, Drug-resistant Tuberculosis Treatment
Tuberculosis

Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests

Press Release 13 Sep 2023
 
MSF, Doctors Without Borders, TB
Tuberculosis

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

Press Release 14 Jul 2023
 
MSF Pharmacist dispensing Bedaquiline and Delamanid based DRTB
Multi-drug Resistant Tuberculosis

TB-PRACTECAL: Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis

Press Release 21 Dec 2022
 
MSF, Doctors without Borders, Daily dosage of pills
Multi-drug Resistant Tuberculosis

Major opportunity to increase access to newer, safer DR-TB drugs is at risk

Press Release 7 Nov 2022
 
MSF Hospital in Bangassou, CAR
Tuberculosis

MSF warns that supply delays of critical TB test will cost lives

Press Release 15 Sep 2022
 
Simphiwe holds his medication, he takes up to 26 pills a day to treat XDR-TB. Here he holds his morning selection, which includes delamanid, one of the newest DR-TB drugs, which Simphiwe is taking for the first time today.
Drug-resistant TB

MSF response: WHO announces positive change to TB treatment guidelines

Press Release 4 May 2022